Skip to main content
SpringerLink
Log in

‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature

  • Review
  • Published:
Journal of Inherited Metabolic Disease

Summary

Gaucher disease is a lysosomal storage disorder, which is classically divided into three types. Type I Gaucher disease is differentiated from types II and III disease by the absence of nervous system involvement. However, an increasing number of reports has emerged on neurological manifestations in patients with type I Gaucher disease. Whether a strict division in three different phenotypes is still valid has been the subject of debate. The main objective of this study was to provide scientific arguments whether a distinction between type I (non-neuronopathic) and types II and III (neuronopathic) Gaucher disease should be maintained. We investigated retrospectively a large Dutch cohort of type I Gaucher disease patients for the prevalence of neurological manifestations and provide an overview of the literature on this topic. A diagnosis of a neurological disease was made 34 times in 75 patients. Forty-five patients reported at least one neurological symptom during the median follow-up time of 11 years. The literature search revealed 86 studies in which type I Gaucher disease patients or carriers of a glucocerebrosidase mutation were described with a neurological disease or a condition which is known to be associated with neurological disease. In conclusion, the term non-neuronopathic Gaucher disease does not seem to be an appropriate characterization of type I Gaucher disease. However, the neurological signs and symptoms in type I Gaucher disease are of a totally different kind from and, in the majority of cases, of much less severity than the signs and symptoms associated with types II and III disease Therefore, type I disease should be classified as a separate phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med 351: 1972–1977.

    CAS  PubMed  Google Scholar 

  • Aharon-Peretz J, Badarny S, Rosenbaum H, Gershoni-Baruch R (2005) Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation. Neurology 65: 1460–1461.

    CAS  PubMed  Google Scholar 

  • Airo R, Gabusi G, Guindani M (1993) Gaucher’s disease associated with monoclonal gammapathy of undetermined significance: a case report. Haematologica 78: 129–131.

    CAS  PubMed  Google Scholar 

  • Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosén I (1999) Prevalence of carpal tunnel syndrome in a general population. JAMA 282: 153–158

    CAS  PubMed  Google Scholar 

  • Bembi B, Marsala SZ, Sidransky E, et al (2003) Gaucher’s disease with Parkinson’s disease: clinical and pathological aspects. Neurology 61: 99–101.

    CAS  PubMed  Google Scholar 

  • Benjamin D, Bouer D, Pick AI, Zer M, Dintdman M, Pinkhas J (1978) Peripheral cryoglobulinemic neuropathy in a patient with Gaucher’s disease. Acta Haematol 60: 117–121.

    CAS  PubMed  Google Scholar 

  • Benjamin D, Joshua H, Djaldetti M, Hazaz B, Pinkhas J (1979) Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher’s disease. Scand J Haematol 22: 179–184.

    CAS  PubMed  Google Scholar 

  • Benson M, Brandt K, Cohen A, Cathcart E (1975) Neuropathy, M components, and amyloid. The Lancet 305: 10–12.

    Google Scholar 

  • Berger LA, Warwick R, Mehta A (2001) Isolated Candida infection of the pterygoid muscles in a patient with Gaucher’s disease. AJR Am J Roentgenol 176: 1332–1333.

    CAS  PubMed  Google Scholar 

  • Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3635–3668.

    Google Scholar 

  • Bischoff A, Reutter FW, Wegmann T (1967) Peripheral nervous system diseases in morbus Gaucher. New data based on electron microscopy. Schweiz Med Wochenschr 97: 1139–1146.

    CAS  PubMed  Google Scholar 

  • Boltshauser EJ, Maria BL (1999) Coexistence of Gaucher disease type 1 and Joubert syndrome. J Med Genet 36: 870–871.

    CAS  PubMed  Google Scholar 

  • Boot RG, Verhoek M, de Fost M, et al (2004) Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 103: 33–39.

    CAS  PubMed  Google Scholar 

  • Brady K, Corash L, Bhargava V (1997) Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher’s disease. Arch Pathol Lab Med 121: 1108–1111.

    CAS  PubMed  Google Scholar 

  • Butora M, Kissling R, Frick P (1989) Bone changes in Gaucher disease. Z Rheumatol 48: 326–330.

    CAS  PubMed  Google Scholar 

  • Chang-Lo M, Yam LT, Rubenstone AI (1967) Gaucher’s disease. Review of the literature and report of twelve new cases. Am J Med Sci 254: 303–335.

    CAS  PubMed  Google Scholar 

  • Charrow J, Esplin JA, Gribble TJ, et al (1998) Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 158: 1754–1760.

    CAS  PubMed  Google Scholar 

  • Clark LN, Nicolai A, Afridi S, et al (2005) Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson’s disease in subjects of Jewish ethnicity. Mov Disord 20: 100–103.

    PubMed  Google Scholar 

  • Cormand B, Vilageliu L, Burguera JM, et al (1995) Gaucher disease in Spanish patients: analysis of eight mutations. Hum Mutat 5: 303–309.

    CAS  PubMed  Google Scholar 

  • Cormand B, Grinberg D, Gort L, Chabas A, Vilageliu L (1998) Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome. Hum Mutat 11: 295–305.

    CAS  PubMed  Google Scholar 

  • Costello R, O’Callaghan T, Sebahoun G (2006) Gaucher disease and multiple myeloma. Leuk Lymphoma 47: 1365–1368.

    PubMed  Google Scholar 

  • Coyne JD, Lynch T, Cotter P, Kealy WF, Duggan PF (1985) Gaucher’s disease: a case report with coincidental vitamin B12 deficiency anaemia. Ir Med J 78: 254–255.

    CAS  PubMed  Google Scholar 

  • Davis M, Dorfman J (1961) Gaucher’s disease associated with a cerebral astrocytoma. A case report involving an adult. Am Pract Dig Treat 12: 673–677.

    CAS  PubMed  Google Scholar 

  • de Fost M, vom Dahl S, Weverling GJ, et al (2006) Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 36: 53–58.

    PubMed  Google Scholar 

  • de la Court A, Breteler MM, Meinardi H, Hauser WA, Hofman A (1996) Prevalence of epilepsy in the elderly: the Rotterdan study. Epilepsia 37: 141–147

    PubMed  Google Scholar 

  • de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinson disease in a general population: the Rotterdam study. Neurology 63: 1240–1244.

    PubMed  Google Scholar 

  • Delpre G, Stark P, Niv Y (2002) B12 deficiency: not an uncommon genetic-related disorder. Br J Haematol 119: 882–883.

    PubMed  Google Scholar 

  • Dikman SH, Goldstein M, Kahn T, Leo MA, Weinreb N (1978) Amyloidosis. An unusual complication of Gaucher’s disease. Arch Pathol Lab Med 102: 460–462.

    CAS  PubMed  Google Scholar 

  • Dispenzieri A, Kyle RA (2005) Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol 18: 673–688.

    CAS  PubMed  Google Scholar 

  • Eblan MJ, Scholz S, Stubblefield BK, et al (2006a) Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism. Neurosci Lett 404: 163–165.

    CAS  PubMed  Google Scholar 

  • Eblan MJ, Nguyen J, Ziegler SG, et al (2006b) Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov Disord 21: 282–283.

    PubMed  Google Scholar 

  • Elstein D, Rosenmann E, Reinus C, Paz J, Altarescu G, Zimran A (2003) Amyloidosis and gastric bleeding in a patient with Gaucher disease. J Clin Gastroenterol 37: 234–237.

    PubMed  Google Scholar 

  • Flipo RM, is-Lavignasse C, Cortet B, Chastanet P, Goudemand J, Duquesnoy B (1992) “Spontaneous” hematoma of the psoas in Gaucher’s disease. Rev Med Interne 13: 293–295.

    CAS  PubMed  Google Scholar 

  • Frankel M, Zimran A, Elstein D (2006) Current perception treshold testing for peripheral neuropathy in type 1 Gaucher disease. Haematologia 9: 264–269.

    Google Scholar 

  • Garfinkel D, Sidi Y, Ben-Bassat M, Salomon F, Hazaz B, Pinkhas J (1982) Coexistence of Gaucher’s disease and multiple myeloma. Arch Intern Med 142: 2229–2230.

    CAS  PubMed  Google Scholar 

  • Gielchinsky Y, Elstein D, Green R, et al (2001) High prevalence of low serum vitamin B12 in a multi-ethnic Israeli population. Br J Haematol 115: 707–709.

    CAS  PubMed  Google Scholar 

  • Goker-Alpan O, Schiffmann R, Park JK, Stubblefield BK, Tayebi N, Sidransky E (2003) Phenotypic continuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3. J Pediatr 143: 273–276.

    PubMed  Google Scholar 

  • Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41: 937–940.

    CAS  PubMed  Google Scholar 

  • Goldblatt J, Sacks S, Beighton P (1978) The orthopedic aspects of Gaucher disease. Clin Orthop Relat Res 137: 208–214.

    PubMed  Google Scholar 

  • Goldblatt J, Keet P, Dall D (1987) Spinal cord decompression for gaucher’s disease. Neurosurgery 21: 227–230.

    CAS  PubMed  Google Scholar 

  • Grabowski GA (2005) Recent clinical progress in Gaucher disease. Curr Opin Pediatr 17: 519–524.

    PubMed  Google Scholar 

  • Grewal RP, Doppelt SH, Thompson MA, Katz D, Brady RO, Barton NW (1991) Neurologic complications of nonneuronopathic Gaucher’s disease. Arch Neurol 48: 1271–1272.

    CAS  PubMed  Google Scholar 

  • Guimaraes J, Amaral O, Sa Miranda MC (2003) Adult-onset neuronopathic form of Gaucher’s disease: a case report. Parkinsonism Relat Disord 9: 261–264.

    CAS  PubMed  Google Scholar 

  • Haan J, Peters WG (1994) Amyloid and peripheral nervous system disease. Clin Neurol Neurosurg 96: 1–9.

    CAS  PubMed  Google Scholar 

  • Halperin A, Elstein D, Zimran A (2006) Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 36: 426–428.

    PubMed  Google Scholar 

  • Halperin A, Elstein D, Zimran A (2007) Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease? Acta Neurol Scand 115: 275–278.

    CAS  PubMed  Google Scholar 

  • Hamlat A, Saikali S, Lakehal M, Pommereuil M, Morandi X (2004) Cauda equina syndrome due to an intra-dural sacral cyst in type-1 Gaucher disease. Eur Spine J 13: 249–252.

    PubMed  Google Scholar 

  • Hanash SM, Rucknagel DL, Heidelberger KP, Radin NS (1978) Primary amyloidosis associated with Gaucher’s disease. Ann Intern Med 89(5 Pt 1): 639–641.

    CAS  PubMed  Google Scholar 

  • Harder H, Eucker J, Zang C, et al (2000) Coincidence of Gaucher’s disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria. Ann Hematol 79: 640–643.

    CAS  PubMed  Google Scholar 

  • Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lucking CH (1998) Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 65: 822–827.

    CAS  PubMed  Google Scholar 

  • Hermann G, Wagner LD, Gendal ES, Ragland RL, Ulin RI (1989) Spinal cord compression in type 1 Gaucher disease. Radiology 170: 147–148.

    CAS  PubMed  Google Scholar 

  • Hoffmann B, Mayatepek E (2005) Neurological manifestations in lysosomal staorage disorders—from pathology to first therapeutic options. Neuropediatrics 36: 285–289.

    CAS  PubMed  Google Scholar 

  • Hrebicek M, Zeman J, Musilova J, et al (1996) A case of type I Gaucher disease with cardiopulmonary amyloidosis and chitotriosidase deficiency. Virchows Arch 429: 305–309.

    CAS  PubMed  Google Scholar 

  • IGPSG (1995) Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in tw Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG). Neurology 45: 1832–1836.

    Google Scholar 

  • Inouye SK (1998) Delirium in hospitalized older patients: recognition and risk factors. J Geriatr Psychiatry Neurol 11: 118–125

    CAS  PubMed  Google Scholar 

  • Itokawa K, Tamura N, Kawai N, Shimazu K, Ishii K (2006) Parkinsonism in type I Gaucher’s disease. Intern Med 45: 1165–1167

    PubMed  Google Scholar 

  • Jmoudiak M, Itzchaki M, Hadas-Halpern I, et al (2003) Iliopsoas hematoma in a young patient with type I Gaucher disease. Isr Med Assoc J 5: 673–674.

    PubMed  Google Scholar 

  • Kaloterakis A, Filiotou A, Koskinas J, et al (1999) Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature. J Intern Med 246: 587–590.

    CAS  PubMed  Google Scholar 

  • Kaminsky P, Klein M, Jacob C, Deibener J, Duc M (1995) Biclonal gammapathy in type I Gaucher disease. Presse Med 24: 1400.

    CAS  PubMed  Google Scholar 

  • Kaplan P, Andersson HC, Kacena KA, Yee JD (2006) The clinical and demographic characteristics of nonneuropathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 160: 603–608.

    PubMed  Google Scholar 

  • Katz K, Sabato S, Horev G, Cohen IJ, Yosipovitch Z (1993) Spinal involvement in children and adolescents with Gaucher disease. Spine 18: 332–335.

    Article  CAS  PubMed  Google Scholar 

  • Katz K, Tamary H, Lahav J, Soudry M, Cohen IJ (1999) Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement. Bull Hosp Jt Dis 58: 188–190.

    CAS  PubMed  Google Scholar 

  • King JO (1975) Progressive myoclonic epilepsy due to Gaucher’s disease in an adult. J Neurol Neurosurg Psychiatry 38: 849–854.

    CAS  PubMed  Google Scholar 

  • Kocher MS, Hall JE (2000) Surgical management of spinal involvement in children and adolescents with Gaucher’s disease. J Pediatr Orthop 20: 383–388.

    CAS  PubMed  Google Scholar 

  • Kono S, Shirakawa K, Ouchi Y, et al (2007) Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier. J Neurol Sci 252: 181–184.

    CAS  PubMed  Google Scholar 

  • Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort. Neurology 53: 537.

    CAS  PubMed  Google Scholar 

  • Lesic A, Suvajdzic N, Elezovic I, et al (2006) Iliopsoas haematoma in Gaucher disease. J Inherit Metab Dis 29: 593.

    PubMed  Google Scholar 

  • Liel Y, Hausmann MJ, Mozes M (1991) Case report: serendipitous Gaucher’s disease presenting as elevated erythrocyte sedimentation rate due to monoclonal gammopathy. Am J Med Sci 301: 393–394.

    CAS  PubMed  Google Scholar 

  • Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 81: 70–73.

    CAS  PubMed  Google Scholar 

  • Lyons JC, Scheithauer BW, Ginsburg WW (1982) Gaucher’s disease and glioblastoma multiforme in two siblings: a clinicopathologic study. J Neuropathol Exp Neurol 41: 45–53.

    CAS  PubMed  Google Scholar 

  • MacDonald M, McCathie M, Faed MJ, et al (1975) Proceedings: Gaucher’s disease with biclonal gammopathy. J Clin Pathol 28: 757.

    CAS  PubMed  Google Scholar 

  • Machaczka M, Rucinska M, Skotnicki AB, Jurczak W (1999) Parkinson’s syndrome preceding clinical manifestation of Gaucher’s disease. Am J Hematol 61: 216–217.

    Google Scholar 

  • Marie JP, Tulliez M, Tricottet-Paczinski V, Reynes M, Diebold J (1982) Gaucher’s disease with monoclonal gammopathy. Significance of splenic plasmacytosis. Scand J Haematol 28: 54–58.

    CAS  PubMed  Google Scholar 

  • Markin RS, Skultety FM (1984) Spinal cord compression secondary to Gaucher’s disease. Surg Neurol 21: 341–346.

    CAS  PubMed  Google Scholar 

  • Marti GE, Ryan ET, Papadopoulos NM, et al (1988) Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol 29: 189–194.

    CAS  PubMed  Google Scholar 

  • McAlarney T, Pastores GM, Hays AP, Latov N (1995) Antisulfatide antibody and neuropathy in a patient with Gaucher’s disease. Neurology 45: 1622–1623.

    CAS  PubMed  Google Scholar 

  • McKeran RO, Bradbury P, Taylor D, Stern G (1985) Neurological involvement in type 1 (adult) Gaucher’s disease. J Neurol Neurosurg Psychiatry 48: 172–175.

    CAS  PubMed  Google Scholar 

  • Melamed E, Cohen C, Soffer D, Lavy S (1975) Central nervous system complication in a patient with chronic Gaucher’s disease. Eur Neurol 13: 167–175.

    CAS  PubMed  Google Scholar 

  • Mercimek-Mahmutoglu S, Gruber S, Wober Ch, Moser E, Stockler-Ipsiroglu S (2004) Evidence of neurological manifestations in patients with type 1 gaucher disease. J Inherit Metab Dis 27(Supplement 1): 153.

    Google Scholar 

  • Miller JD, McCluer R, Kanfer JN (1973) Gaucher’s disease: neurologic disorder in adult siblings. Ann Intern Med 78: 883.

    CAS  PubMed  Google Scholar 

  • Miller W, Lamon JM, Tavassoli M, Longmire R, Beutler E (1982) Multiple myeloma complicating Gaucher’s disease. West J Med 136: 122–128.

    Google Scholar 

  • Mygland A, Monstad P (2001) Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 8:157–165

    CAS  PubMed  Google Scholar 

  • Neau P, Mercier P, Bouabdallah K, et al (1993) Une étiologie rare de compression médullaire: la maladie de Gaucher. Rev Med Interne 14: 260–262.

    CAS  PubMed  Google Scholar 

  • Neil JF, Glew RH, Peters SP (1979a) Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher’s disease. Arch Neurol 36: 95–99.

    CAS  PubMed  Google Scholar 

  • Neil JF, Merikangas JR, Glew RH (1979b) EEG findings in adult neuronopathic Gaucher’s disease. Clin Electroencephalogr 10: 198–205.

    CAS  PubMed  Google Scholar 

  • Neudorfer O, Giladi N, Elstein D, et al (1996) Occurence of Parkinson’s syndrome in type 1 Gaucher disease. Q J Med 89: 691–694.

    CAS  Google Scholar 

  • Orvisky E, Park JK, LaMarca ME, et al (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab 76: 262–270.

    CAS  PubMed  Google Scholar 

  • Ott A, Breteler MM, van Harskamp F, et al (1995) Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 310: 970–973.

    CAS  PubMed  Google Scholar 

  • Pastores GM, Barnett NL, Bathan P, Kolodny EH (2003) A neurological symptom survey of patients with type 1 Gaucher disease. J Inherit Metab Dis 26: 641–645.

    CAS  PubMed  Google Scholar 

  • Peitersen E (1982) The natural history of Bell’s palsy. Am J Otol 4: 107–111

    CAS  PubMed  Google Scholar 

  • Pérez-Calvo J, Bernal M, Giraldo P, et al (2000) Co-morbidity in Gaucher’s disease results of a nationwide enquiry in Spain. Eur J Med Res 5: 231–235.

    PubMed  Google Scholar 

  • Pinkhas J, Djaldetti M, Yaron M (1965) Coincidence of multiple myeloma with Gaucher’s disease. Isr J Med Sci 1: 537–540.

    CAS  PubMed  Google Scholar 

  • Pratt PW, Kochwa S, Estren S (1968) Immunoglobulin abnormalities in Gaucher’s disease. Report of 16 cases. Blood 31: 633–640.

    CAS  PubMed  Google Scholar 

  • Rachmilewitz EA, Kornberg A, Acker M (1982) Vitamin E deficiency due to increased consumption in beta-thalassemia and in Gaucher’s disease. Ann N Y Acad Sci 393: 336–347.

    CAS  PubMed  Google Scholar 

  • Raynor BB (1962) Spinal-cord compression secondary to Gaucher’s disease. Case report. J Neurosurg 19: 902–905.

    Article  CAS  PubMed  Google Scholar 

  • Ruestow PC, Levinson DJ, Catchatourian R, Sreekanth S, Cohen H, Rosenfeld S (1980) Coexistence of IgA myeloma and Gaucher’s disease. Arch Intern Med 140: 1115–1116.

    CAS  PubMed  Google Scholar 

  • Rymer MM, Kao CC (1974) Pitfalls in the diagnosis of low-back and leg pain. Postgrad Med 56: 76–80.

    CAS  PubMed  Google Scholar 

  • Sato C, Morgan A, Lang AE, et al (2005) Analysis of the glucocerebrosidase gene in Parkinson’s disease. Mov Disord 20: 367–370.

    PubMed  Google Scholar 

  • Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J (1982) Gaucher’s disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106: 388–391.

    CAS  PubMed  Google Scholar 

  • Shvidel L, Hurwitz N, Shtalrid M, Zur S, Oliver O, Berrebi A (1995) Complex IgA gammopathy in Gaucher’s disease. Leuk Lymphoma 20: 165–168.

    CAS  PubMed  Google Scholar 

  • Sidransky E (2004) Gaucher disease: complexity in a “simple” disorder. Mol Genet Metab 83: 6–15.

    CAS  PubMed  Google Scholar 

  • Soffer D, Yamanaka T, Wenger DA, Suzuki K (1980) Central nervous system involvement in adult-onset Gaucher disease. Acta Neuropathol 49: 1–6.

    CAS  PubMed  Google Scholar 

  • Spitz M, Rozenberg R, Silveira PAA, Barbosa ER (2006) Parkinsonism in type 1 Gaucher’s disease. J Neurol Neurosurg Psychiatry 77: 709–710.

    CAS  PubMed  Google Scholar 

  • Tanyel MC, Mancano LD (1997) Neurologic findings in vitamin E deficiency. Am Fam Physician 55: 197–201.

    CAS  PubMed  Google Scholar 

  • Tayebi N, Callahan M, Madike V, et al (2001) Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 73: 313–321.

    CAS  PubMed  Google Scholar 

  • Tayebi N, Walker JM, Stubblefield BK, et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79: 104–109.

    CAS  PubMed  Google Scholar 

  • Turesson I, Rausing A (1975) Gaucher’s disease and benign monoclonal gammapathy. A case report with immunofluorescence study of bone marrow and spleen. Acta Med Scand 197: 507–512.

    CAS  PubMed  Google Scholar 

  • Tylki-Szymanska A, Millat G, Maire I, Czartoryska B (1996) Types I and III Gaucher disease in Poland: incidence of the most common mutations and phenotypic manifestations. Eur J Hum Genet 4: 334–337.

    CAS  PubMed  Google Scholar 

  • van Royen-Kerkhof A, Poll-The BT, Kleijer WJ, et al (1998) Coexistence of Gaucher disease type 1 and Joubert syndrome. J Med Genet 35: 965–966.

    PubMed  Google Scholar 

  • Várkonyi J, Simon Z, Soós K (2002) Gaucher disease type 1 complicated with Parkinson’s syndrome. Haematologia 32: 271–275.

    PubMed  Google Scholar 

  • Várkonyi J, Rosenbaum H, Baumann N, et al (2003) Gaucher disease associated with parkinsonism: four further case reports. Am J Med Genet 116A: 348–351.

    PubMed  Google Scholar 

  • Vellodi A, Bembi B, De Villemeur TB, et al (2001) Management of neuronopathic Gaucher disease: a European consensus. J Inherit Metab Dis 24: 319–327.

    CAS  PubMed  Google Scholar 

  • Winkelman MD, Banker BQ, Victor M, Moser HW (1983) Non-infantile neuronopathic Gaucher’s disease: a clinicopathologic study. Neurology 33: 994–1008.

    CAS  PubMed  Google Scholar 

  • Wong K, Sidransky E, Verma A, et al (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 82: 192–207.

    CAS  PubMed  Google Scholar 

  • Ziegler SG, Eblan MJ, Gutti U, et al (2007) Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 91: 195–200.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands

    M. Biegstraaten & I. N. van Schaik

  2. Department of Biochemistry, Academic Medical Centre, Amsterdam, The Netherlands

    J. M. F. G. Aerts

  3. Department of Internal Medicine, Division of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands

    C. E. M. Hollak

Authors
  1. M. Biegstraaten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. N. van Schaik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. M. F. G. Aerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. E. M. Hollak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. E. M. Hollak.

Additional information

Communicating editor: Guy Besley

Competing interests: None declared

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biegstraaten, M., van Schaik, I.N., Aerts, J.M.F.G. et al. ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis 31, 337–349 (2008). https://doi.org/10.1007/s10545-008-0832-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-008-0832-y

Keywords

Search

Navigation